Licarin A is a candidate compound for the treatment of immediate hypersensitivity via inhibition of rat mast cell line RBL-2H3 cells

Takuya Matsui(Aichi Medical University), Masataka Itoigawa(Tokai Gakuen University)
Journal of Pharmacy and Pharmacology
September 17, 2015
Cited by 19


Related Papers

No related papers found

Powered by citation graph analysis